Scientists say new drugs are on the way for patients with ALS. The latest is a two-drug combo that appears to slow the progression of the fatal nerve disease with a modest but meaningful benefit.
Multiple studies now confirm earlier research: Dexamethasone and hydrocortisone, drugs that reduce an immune system's overreaction, can help reduce deaths of hospitalized COVID-19 patients.
Certain diagnoses are harder to catch without an in-person connection. And beyond that, a doctor reflects on the loss of a ritual that can provide "real comfort and meaning" to physician and patient.
A vaccine against the coronavirus needs to keep people from getting very sick and dying. But preventing the spread of the disease is also important, and vaccines delivered by nasal spray may do that.
New vaccines usually take years to get the approval of the Food and Drug Administration. But the Trump administration suggests the FDA may greenlight a coronavirus vaccine by the end of the year.
Young athletes — especially girls — can struggle with a breathing problem that appears to be asthma. The real cause of the problem is in the vocal cords.
Doctors are researching why some patients remain unconscious for days or weeks, even after sedating drugs are withdrawn. They also worry that these patients aren't being given time to recover.
The federal government is in charge of distributing one of the few treatment options for COVID-19: the antiviral drug remdesivir. But how are decisions made about which states need it most?
After six weeks on a ventilator, she was dying of COVID-19. But doctors took a gamble and gave Mayra Ramirez a double lung transplant. Now she shares what it's like to come back from the brink.
Moderna, one of the leading horses in the coronavirus vaccine race, has already made deals at between $32 and $37 a dose for some foreign countries. The U.S. price is expected to be lower.
Adjuvants play a crucial role in many vaccines' effectiveness. Some scientists say there needs to be more research into developing a wider variety of adjuvants because of how important they are.
For many cancer patients, daily life can feel full of risky choices involving work, family, friends and money. Nearly every option pits the risks of catching the coronavirus against other downsides.
The National Institutes of Health is giving $248.7 million dollars to seven companies developing new technologies for testing, including use of the revolutionary gene-editing technique CRISPR.
